Pancreatic Cancer Research

ResearcherBakırköy Dr.Sadi Konuk Eğitim ve Araştırma HastanesiActive in the last 2 years

İlkay Gültürk

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1998-3150; OpenAlex author ID A5030535629. Sources: OpenAlex.

Their work

Papers
4
Trials
0
Grants
0
Labs led
0
Collaborators
12
Papers, trials and grants by year

2024: 1 paper · 2025: 2 papers · 2026: 1 paper

Papers 4

  1. Correction: Efficacy of gemcitabine plus nab-paclitaxel in second-line treatment of metastatic pancreatic cancer. Co-author DOI 10.1038/s41598-026-47335-7↗
  2. Efficacy of gemcitabine plus nab-paclitaxel in second-line treatment of metastatic pancreatic cancer. Co-author DOI 10.1038/s41598-025-96157-6↗
  3. The Prognostic Value of the EASIX Score in Patients with Metastatic Pancreatic Cancer. Co-author DOI 10.3390/diagnostics15141740↗
  4. Naples prognostic score may predict overall survival in metastatic pancreatic cancer. Co-author DOI 10.4103/jcrt.jcrt_1392_22↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Nargız Majidova · 2 shared papers, 2025–2026 · strength 0.34
  2. Melike Özçelik · 2 shared papers, 2025–2026 · strength 0.34
  3. Abdullah Sakin · 2 shared papers, 2025–2026 · strength 0.34
  4. Yasin Sezgin · 2 shared papers, 2025–2026 · strength 0.34
  5. Bilgin Demir · 2 shared papers, 2025–2026 · strength 0.34
  6. Yakup Ergün · 2 shared papers, 2025–2026 · strength 0.34
  7. Çiğdem Usul Afşar · 1 shared paper, 2025 · strength 0.28
  8. Vahit Can Çavdar · 1 shared paper, 2025 · strength 0.28
  9. Gülçin Şahingöz Erdal · 1 shared paper, 2024 · strength 0.23
  10. Oğuz Kağan Bakkaloğlu · 1 shared paper, 2024 · strength 0.23
  11. Deniz Tural · 1 shared paper, 2024 · strength 0.23
  12. Mustafa Yıldırım · 1 shared paper, 2025 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.